- ¥429.90 - 7999.90
- 阿拉丁
- 上海
- Ab095034
- 2026年05月09日
企业认证
相关产品推荐更多 >
Recombinant CD20 Antibody (PE)，阿拉丁
￥449.90
Human IgG3 (AF594)，ExactAb™, 已验证, 重组, 0.5 mg/mL，阿拉丁
¥999.90
CBZ/Carbamazepine Mouse mAb，≥95%(SEC-HPLC), 见COA，阿拉丁
¥199.90
Human IgG3 (AF700)，ExactAb™, 已验证, 重组, 0.5 mg/mL，阿拉丁
¥999.90HE4 Mouse mAb，ExactAb™, Validated, Carrier Free, Azide Free, Lot by Lot，阿拉丁
￥869.90
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 亚型：
Mouse IgM
- 保存条件：
2-8°C储存；低温运输
- 库存：
现货
- 供应商：
上海阿拉丁生化科技股份有限公司
- 浓度：
见COA
- 规格：
Ab095034-100μl/Ab095034-10μl/Ab095034-1ml/Ab095034-50μl
| 规格： | Ab095034-100μl | 产品价格： | ¥1799.90 |
|---|---|---|---|
| 规格： | Ab095034-10μl | 产品价格： | ¥429.90 |
| 规格： | Ab095034-1ml | 产品价格： | ¥7999.90 |
| 规格： | Ab095034-50μl | 产品价格： | ¥1299.90 |
基本信息
产品名称：Recombinant CD57 Antibody
规格或纯度：重组, ExactAb™, 已验证, 见COA
应用：IHC
特异性：CD57
种属反应性：人(Human)
阳性对照：IHC: Human tonsil tissue.
偶联：Unconjugated
产品属性
克隆类型：重组抗体
克隆号：MyM1-CD57
Format：IgM
亚型：Mouse IgM
轻链亚型：kappa
纯化方法：Protein A purified
物理外观：Liquid
储存缓冲液：50mM Tris-HCl, 15mM Sodium azide, ＜1.0% BSA, pH7.2
防腐剂：15mM Sodium azide
浓度：见COA
储存条件：2-8°C储存
运输条件：低温运输
稳定性与储存：短期储存2-8℃（36个月）；收货后建议分装。
功能和特点
宿主种属：小鼠(Mouse)
种属反应性：人(Human)
偶联：Unconjugated
图片
Recombinant CD57 Antibody (Ab095034) - IHC
Immunohistochemistry analysis of paraffin-embedded Human tonsil tissue labelling CD57 with Recombinant CD57 Antibody (Ab095034) at 1/100 dilution. The section was incubated with Ab095034 for 30 mins at room temperature. Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 was used for antigen retrieval.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Antibody Validation by Western Blotting
must be thoroughly demonstrated using a complex biological sample, rather than a recombinant protein, prior to use in clinical translational research. In the simplest iteration, antibody specificity is determined by the presence of a single band in a complex
Production of Monoclonal Antibody by DNA Immunization with Electroporation
associated with problematic antigens: low abundance and protein instability and use of recombinant proteins that lack posttranslational modifications. This chapter describes the use of a DNA-based immunization protocol for the production of mAb
VERIFY overexpression lysate antigen standards （Lane 1 to 7） were fractionated on SDS-PAGE, and then immunoblotted with 8F1 （Upper panel）。 The recombinant protein expression levels within the lysates were analyzed with anti-DDK antibody （Lower panel
技术资料暂无技术资料 索取技术资料
